Please login to the form below

Not currently logged in
Email:
Password:

Dr Catherine Strader joins Acorda Therapeutics’ board

She brings experience from Merck & Co and Synergy Partners R&D Solutions

Acorda Therapeutics has expanded its board of directors with the addition of Dr Catherine Strader.

Dr Strader is currently a founding partner at Synergy Partners R&D Solutions, and prior to co-founding the drug discovery and development network in 2014 was vice president and discovery site head at Merck & Co's New Jersey hub.

She also brings executive leadership experience from Schering-Plough, where she served as executive vice president of discovery research and chief scientific officer between 2002 and 2007.

Dr Ron Cohen, Acorda's president and chief executive officer, said: “Catherine brings decades of experience as both a drug developer and biopharmaceutical business executive with an outstanding track record of achievement.

“I expect her to add significant value to the board and the company as we continue to develop our pipeline and grow our business.”

23rd February 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics